Alejandro Marques-Olive

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Mepolizumab efficacy and safety in patients with eosinophilic granulomatosis with polyangiitis in real practice: Data from a Spanish retrospective multicentric register from Rheumatology departments.

Mepolizumab efficacy and safety in patients with eosinophilic granulomatosis with polyangiitis in real practice: Data from a Spanish retrospective multicentric register from Rheumatology departments.

Journal: Reumatologia clinica

Published: April 16, 2024

Clinical characteristics and risk factors associated with lymphoma in patients with systemic lupus erythematosus: a nationwide cohort study.

Clinical characteristics and risk factors associated with lymphoma in patients with systemic lupus erythematosus: a nationwide cohort study.

Journal: Rheumatology (Oxford, England)

Published: January 11, 2022

Association between hematopoietic stem cell transplantation and Parsonage Turner syndrome: coincidence or cause-effect relationship?

Association between hematopoietic stem cell transplantation and Parsonage Turner syndrome: coincidence or cause-effect relationship?

Journal: Rehabilitacion

Published: December 31, 2021

Comment: The reality of rheumatology in Spain and its autonomous communities before the pandemic.

Comment: The reality of rheumatology in Spain and its autonomous communities before the pandemic.

Journal: Reumatologia clinica

Published: November 04, 2021

Long-term survival of biological therapy in psoriatic arthritis: 18-year analysis of a cohort in a tertiary hospital.

Long-term survival of biological therapy in psoriatic arthritis: 18-year analysis of a cohort in a tertiary hospital.

Journal: Rheumatology international

Published: April 07, 2021

Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?

Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?

Journal: Rheumatology (Oxford, England)

Published: February 14, 2021

Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality.

Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality.

Journal: Lupus

Published: August 19, 2020

Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?

Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?

Journal: Clinical and experimental rheumatology

Published: March 26, 2020

Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice.

Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice.

Journal: Clinical and experimental rheumatology

Published: January 17, 2020

Rheumatology Manpower in the Public System in Catalonia (Spain).

Rheumatology Manpower in the Public System in Catalonia (Spain).

Journal: Reumatologia clinica

Published: December 21, 2019

Rheumatology manpower in the public system in Catalonia (Spain).

Rheumatology manpower in the public system in Catalonia (Spain).

Journal: Reumatologia clinica

Published: December 21, 2019

PAN-like necrotizing vasculitis in primary Sjögren syndrome: 5 cases.

PAN-like necrotizing vasculitis in primary Sjögren syndrome: 5 cases.

Journal: Medicina clinica

Published: October 21, 2019

Showing 1-12 of 28

Last Updated: 09/26/2026